Protein Therapeutics World Report 2017 Industry Report By Characteristics, Analysis,Opportunities And Forecast to 2021

Protein Therapeutics

 About this Report

Therapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis (RA), ankylosing spondylitis, diabetes; infections such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases related to kidney dialysis, and cancer-related anemia. Therapeutic proteins mostly consist of recombinant forms of naturally occurring proteins.

Technavio’s analysts forecast the global protein therapeutics market to grow at a CAGR of 7.86% during the period 2017-2021.

Request For Sample Report@
Covered in this Report 
The report covers the present scenario and the growth prospects of the global protein therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and biosimilar drugs used for the treatment of various diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Protein Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• AbbVie
• Amgen
• F. Hoffmann-La Roche
• Johnson & Johnson
• Merck
• Novo Nordisk
Other prominent vendors
• Anhui Anke Biotechnology (Group)
• AstraZeneca
• Baxter International
• Biocon
• Biodel
• BioGenomics
• Biopartners
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Celltrion
• Chugai Pharmaceutical
• Diamyd Medical
• Diasome Pharmaceuticals
• DiaVacs
• Dynavax Technologies
• Eli Lilly
• Ferring Pharmaceuticals
• Generex Biotechnology
• GeneScience Pharmaceuticals
• Hualan Biological Engineering
• Intas Pharmaceuticals
• Ipsen
• JCR Pharmaceuticals
• Kyowa Hakko Kirin
• Lexicon Pharmaceuticals
• LG Life Sciences
• MacroGenics
• MannKind
• Oramed Pharmaceuticals
• Osiris Therapeutics
• Pfizer
• Sandoz International
• Sanofi
• Teva Pharmaceutical Industries
• Thermalin Diabetes
• Tolerion
• Wockhardt
Market driver
• Increased demand for mAbs
• For a full, detailed list, view our report

Market challenge
• Complexities in manufacturing, storage conditions, distribution policies, and high cost
• For a full, detailed list, view our report

Market trend
• Emergence of next-generation biologics
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

For any Questions or Special Requirements related to Protein Therapeutics Report  you can write us @

 List of Abbreviations
PART 01: Executive summary
• Alternate therapies hinder the growth possibilities of approved therapies
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Highlights
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by product type
• Global mAbs market
• Global human insulin market
• Global clotting factors market
• Global EPO market
• Global human growth hormone market
PART 07: Market segmentation by therapy area
• Metabolic and endocrine disorders
• Hematopoiesis
• Fertility
• Cancer
• Autoimmune diseases
• Infectious diseases
• Protein vaccine
PART 08: Market segmentation by protein function
• Enzymatic and regulatory activity
• Special targeting activity
• Vaccines
• Protein diagnostics
PART 09: Geographical segmentation
• Protein therapeutics market in Americas
• Protein therapeutics market in EMEA
• Protein therapeutics market in APAC
PART 10: Market drivers
• Increased demand for mAbs
• Development of novel therapies using innovative technologies
• Availability of favorable reimbursement policies
PART 11: Impact of drivers
PART 12: Market challenges
• Complexities in manufacturing, storage conditions, distribution policies, and high cost
• Complicated regulatory framework
• Alternate therapies loom large
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Emergence of next-generation biologics
• Advent of biosimilars expected to improve the treatment rates
• Strategic alliances further boost the R&D efforts
PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2016
• Other prominent vendors
PART 16: Key vendor analysis
• F. Hoffmann-La Roche
• Novo Nordisk
• Amgen
• AbbVie
• Johnson & Johnson
• Merck
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio

For Discount Report:

Visit to our official website on Linkedin@



Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s